Bain Capital Life Sciences Investors, LLC Q4 2022 Filing

Filed February 14, 2023

Portfolio Value

$894.8B

Holdings

33

Report Date

Q4 2022

Filing Type

13F-HR

All Holdings (33 positions)

#StockSharesValue% PortfolioType
1
SWTXSPRINGWORKS THERAPEUTICS INC
4,831,307$125.7B14.04%
2
NUVLNUVALENT INC
3,577,267$106.5B11.90%
3
NAMSNEWAMSTERDAM PHARMA COMPANY
8,300,000$90.5B10.11%
4
NTRANATERA INC
1,400,000$56.2B6.28%
5
MERSANA THERAPEUTICS INC
8,663,673$50.8B5.67%
6
ARQTARCUTIS BIOTHERAPEUTICS INC
3,000,000$44.4B4.96%
7
CRNXCRINETICS PHARMACEUTICALS IN
2,305,558$42.2B4.71%
8
DVAXDYNAVAX TECHNOLOGIES CORP
3,915,000$41.7B4.66%
9
PHVSPHARVARIS N V
3,180,601$35.8B4.00%
10
CARAEURCARA THERAPEUTICS INC
2,696,030$29.0B3.24%
11
PTGXPROTAGONIST THERAPEUTICS INC
2,364,410$25.8B2.88%
12
ANNXANNEXON INC
4,886,616$25.3B2.82%
13
EQRX INC
10,003,573$24.6B2.75%
14
CTIC1USDCTI BIOPHARMA CORP
3,777,308$22.7B2.54%
15
NRIXNURIX THERAPEUTICS INC
1,822,883$20.0B2.24%
16
YB4PSAVARA INC
11,622,598$18.0B2.01%
17
SLDBSOLID BIOSCIENCES INC
3,130,422$16.8B1.88%
18
TNGXTANGO THERAPEUTICS INC
1,921,790$13.9B1.56%
19
TSVT*2SEVENTY BIO INC
1,408,901$13.2B1.48%
20
ASNSUSDX4 PHARMACEUTICALS INC
12,202,510$12.1B1.35%
21
AVIRATEA PHARMACEUTICALS INC
2,485,638$12.0B1.34%
22
ACADACADIA PHARMACEUTICALS INC
701,402$11.2B1.25%
23
CCCCC4 THERAPEUTICS INC
1,642,210$9.7B1.08%
24
RPIDRAPID MICRO BIOSYSTEMS INC
8,434,560$9.5B1.07%
25
SYRSSYROS PHARMACEUTICALS INC
2,124,694$7.6B0.85%
26
XLOXILIO THERAPEUTICS INC
2,805,413$7.5B0.84%
27
MRNS*MARINUS PHARMACEUTICALS INC
1,431,058$5.7B0.64%
28
THRDTHIRD HARMONIC BIO INC
1,151,657$5.0B0.55%
29
NAUTNAUTILUS BIOTECHNOLOGY INC
2,000,000$3.6B0.40%
30
IVVDINVIVYD INC
1,937,207$2.9B0.32%
31
APTINYX INC
8,891,758$2.5B0.28%
32
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
5,347,689$2.4B0.27%
33
NAMSNEWAMSTERDAM PHARMA COMPANY
100,000$86.0M0.01%